Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tahereh Damghani

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Molecular Diversity|September 21, 2013
Sulfonoketenimides as key intermediates for the synthesis of 2-thioxo-2H-1,3-thiazines and 2-arylimino-2H-1,3-thiazinesIssa Yavari, Manijeh Nematpour, Tahereh Damghani
Journal of Receptor and Signal Transduction Research|June 15, 2022
<i>In silico</i> screening of c-Met tyrosine kinase inhibitors targeting nucleotide and drug-substrate binding sites of ABCB1 as potential MDR reversal agentsFatemeh Moosavi, Tahereh Damghani, Somayeh Ghazi, et al.
Journal of Receptor and Signal Transduction Research|March 5, 2020
Dual potent c-Met and ALK inhibitors: from common feature pharmacophore modeling to structure based virtual screeningSomayeh Pirhadi, Tahereh Damghani, Mohammad Sadegh Avestan, et al.
Molecular Diversity|July 11, 2021
Type II c-Met inhibitors: molecular insight into crucial interactions for effective inhibitionTahereh Damghani, Maryam Elyasi, Somayeh Pirhadi, et al.
ACS Medicinal Chemistry Letters|February 13, 2026
Structural Studies of Fourth-Generation EGFR Inhibitors Reveal Insights into Selective T790M and C797S TargetingTahereh Damghani, Shenghan Song, Kaly S Lin, et al.
Combinatorial Chemistry & High Throughput Screening|November 8, 2019
Clustering and Sampling of the c-Met Conformational Space: A Computational Drug Discovery StudyKorosh Mashayekh, Shahrzad Sharifi, Tahereh Damghani, et al.
European Journal of Pharmacology|January 11, 2021
Antiproliferative effect, alteration of cancer cell cycle progression and potential MET kinase inhibition induced by 3,4-dihydropyrimidin-2(1H)-one C5 amide derivativesFatemeh Moosavi, Ahmad Ebadi, Maryam Mohabbati, et al.
Methods in Enzymology|May 28, 2023
Structural elements that enable specificity for mutant EGFR kinase domains with next-generation small-molecule inhibitorsTahereh Damghani, Florian Wittlinger, Tyler S Beyett, et al.
Journal of Receptor and Signal Transduction Research|October 30, 2019
Prediction of cytotoxic activity of a series of 1H-pyrrolo[2,3-b]pyridine derivatives as possible inhibitors of c-Met using molecular fingerprintsTahereh Damghani, Korosh Mashayekh, Somayeh Pirhadi, et al.
Scientific Reports|September 6, 2023
Novel quinazoline-1,2,3-triazole hybrids with anticancer and MET kinase targeting propertiesMotahareh Mortazavi, Masoomeh Eskandari, Fatemeh Moosavi, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Molecular Diversity|September 21, 2013
Sulfonoketenimides as key intermediates for the synthesis of 2-thioxo-2H-1,3-thiazines and 2-arylimino-2H-1,3-thiazinesIssa Yavari, Manijeh Nematpour, Tahereh Damghani
Journal of Receptor and Signal Transduction Research|June 15, 2022
<i>In silico</i> screening of c-Met tyrosine kinase inhibitors targeting nucleotide and drug-substrate binding sites of ABCB1 as potential MDR reversal agentsFatemeh Moosavi, Tahereh Damghani, Somayeh Ghazi, et al.
Journal of Receptor and Signal Transduction Research|March 5, 2020
Dual potent c-Met and ALK inhibitors: from common feature pharmacophore modeling to structure based virtual screeningSomayeh Pirhadi, Tahereh Damghani, Mohammad Sadegh Avestan, et al.
Molecular Diversity|July 11, 2021
Type II c-Met inhibitors: molecular insight into crucial interactions for effective inhibitionTahereh Damghani, Maryam Elyasi, Somayeh Pirhadi, et al.
ACS Medicinal Chemistry Letters|February 13, 2026
Structural Studies of Fourth-Generation EGFR Inhibitors Reveal Insights into Selective T790M and C797S TargetingTahereh Damghani, Shenghan Song, Kaly S Lin, et al.
Combinatorial Chemistry & High Throughput Screening|November 8, 2019
Clustering and Sampling of the c-Met Conformational Space: A Computational Drug Discovery StudyKorosh Mashayekh, Shahrzad Sharifi, Tahereh Damghani, et al.
European Journal of Pharmacology|January 11, 2021
Antiproliferative effect, alteration of cancer cell cycle progression and potential MET kinase inhibition induced by 3,4-dihydropyrimidin-2(1H)-one C5 amide derivativesFatemeh Moosavi, Ahmad Ebadi, Maryam Mohabbati, et al.
Methods in Enzymology|May 28, 2023
Structural elements that enable specificity for mutant EGFR kinase domains with next-generation small-molecule inhibitorsTahereh Damghani, Florian Wittlinger, Tyler S Beyett, et al.
Journal of Receptor and Signal Transduction Research|October 30, 2019
Prediction of cytotoxic activity of a series of 1H-pyrrolo[2,3-b]pyridine derivatives as possible inhibitors of c-Met using molecular fingerprintsTahereh Damghani, Korosh Mashayekh, Somayeh Pirhadi, et al.
Scientific Reports|September 6, 2023
Novel quinazoline-1,2,3-triazole hybrids with anticancer and MET kinase targeting propertiesMotahareh Mortazavi, Masoomeh Eskandari, Fatemeh Moosavi, et al.
Pageof 2